Computerized testing augments pencil-and-paper tasks in measuring HIV-associated mild cognitive impairment

HIV Medicine

Volumn 12, Issue 8, 2011, Pages 472-480

  Koski, Lisa ^a,b   Brouillette, M J ^c,d   Lalonde, R ^a,d   Hello, B ^b   Wong, E ^b   Tsuchida, A ^b   Fellows, L K ^a,b,e  

^a RESEARCH INSTITUTE OF THE MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c MCGILL UNIVERSITY   (Canada)

^d MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^e MCGILL UNIVERSITY   (Canada)

Author keywords

Executive function; HIV associated neurocognitive disorder; Rasch analysis; Test development

Indexed keywords

ACCURACY; ADULT; ARTICLE; AUTOMATION; BRAIN FUNCTION; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; MONTREAL COGNITIVE ASSESSMENT; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; PSYCHOMETRY; TASK PERFORMANCE;

EID: 79961204669     PISSN: 14642662     EISSN: 14681293     Source Type: Journal    
DOI: 10.1111/j.1468-1293.2010.00910.x     Document Type: Article

References (42)

1. McCutchan JA, Wu JW, Robertson K et al. HIV suppression by HAART preserves cognitive function in advanced, immune-reconstituted AIDS patients. AIDS 2007; 21: 1109-1117.
2. Cysique LA, Vaida F, Letendre S et al. Dynamics of cognitive change in impaired HIV-positive patients initiating antiretroviral therapy. Neurology 2009; 73: 342-348.
3. Price RW, Spudich S. Antiretroviral therapy and central nervous system HIV type 1 infection. J Infect Dis 2008; 197: S294-S306.
4. Robertson KR, Smurzynski M, Parsons TD et al. The prevalence and incidence of neurocognitive impairment in the HAART era. AIDS 2007; 21: 1915-1921.
5. Valcour V, Shikuma C, Shiramizu B et al. Higher frequency of dementia in older HIV-1 individuals: the Hawaii aging with HIV-1 cohort. Neurology 2004; 63: 822-827.
6. Hardy DJ, Vance DE. The neuropsychology of HIV/AIDS in older adults. Neuropsychol Rev 2009; 19: 263-272.
7. Becker JT, Lopez OL, Dew MA et al. Prevalence of cognitive disorders differs as a function of age in HIV virus infection. AIDS 2004; 18: S11-S18.
8. Cherner M, Ellis RJ, Lazzaretto D et al. Effects of HIV-1 infection and aging on neurobehavioral functioning: preliminary findings. AIDS 2004; 18: S27-S34.
9. Antinori A, Arendt G, Becker JT et al. Updated research nosology for HIV-associated neurocognitive disorders. Neurology 2007; 69: 1789-1799.
10. Everall I, Vaida F, Khanlou N et al. Cliniconeuropathologic correlates of human immunodeficiency virus in the era of antiretroviral therapy. J Neurovirol 2009; 15: 360-370.
11. Cherry CL, Affandi JS, Brew BJ et al. Hepatitis C seropositivity is not a risk factor for sensory neuropathy among patients with HIV. Neurology 2010; 74: 1538-1542.
12. Garvey LJ, Yerrakalva D, Winston A. Correlations between computerized battery testing and a memory questionnaire for identification of neurocognitive impairment in HIV type 1-infected subjects on stable antiretroviral therapy. AIDS Res Hum Retroviruses 2009; 25: 765-769.
13. Millikin CP, Rourke SB, Halman MH, Power C. Fatigue in HIV/AIDS is associated with depression and subjective neurocognitive complaints but not neuropsychological functioning. J Clin Exp Neuropsychol 2003; 25: 201-215.
14. Simioni S, Cavassini M, Annoni JM et al. Cognitive dysfunction in HIV patients despite long-standing suppression of viremia. AIDS 2010; 24: 1243-1250.
15. Deutsch R, Mindt MR, Xu R, Cherner M, Grant I, Group TH. Quantifying relative superiority among many binary-valued diagnostic tests in the presence of a gold standard. J Data Sci 2009; 7: 161-177.
16. Skinner S, Adewale AJ, DeBlock L, Gill MJ, Power C. Neurocognitive screening tools in HIV/AIDS: comparative performance among patients exposed to antiretroviral therapy. HIV Med 2009; 10: 246-252.
17. Bond TG, Fox CM. Applying the Rasch Model: Fundamental Measurement in the Human Sciences, 2nd ed. Mahwah: Laurence Erlbaum Associates, 2007.
18. Nasreddine ZS, Phillips NA, Bedirian V et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 2005; 53: 695-699.
19. Smith T, Gildeh N, Holmes C. The Montreal Cognitive Assessment: validity and utility in a memory clinic setting. Can J Psychiatry 2007; 52: 329-332.
20. Gibbie T, Mijch A, Ellen S et al. Depression and neurocognitive performance in individuals with HIV/AIDS: 2-year follow-up. HIV Med 2006; 7: 112-121.
21. Maruff P, Thomas E, Cysique L et al. Validity of the CogState Brief Battery: relationship to standardized tests and sensitivity to cognitive impairment in mild traumatic brain injury, schizophrenia, and aids dementia complex. Arch Clin Neuropsychol 2009; 24: 165-178.
22. Koski L, Xie H, Finch L. Measuring cognition in a geriatric outpatient clinic: Rasch analysis of the Montreal Cognitive Assessment. J Geriatr Psychiatry Neurol 2009; 22: 151-160.
23. Jones RN, Gallo JJ. Dimensions of the Mini-Mental State Examination among community dwelling older adults. Psychol Med 2000; 30: 605-618.
24. Schultz-Larsen K, Kreiner S, Lomholt RK. Mini-Mental Status Examination: mixed Rasch model item analysis derived two different cognitive dimensions of the MMSE. J Clin Epidemiol 2007a; 60: 268-279.
25. Schultz-Larsen K, Lomholt RK, Kreiner S. Mini-Mental Status Examination: a short form of MMSE was as accurate as the original MMSE in predicting dementia. J Clin Epidemiol 2007b; 60: 260-267.
26. Wouters H, Zwinderman AH, van Gool WA, Schmand B, Lindeboom R. Adaptive cognitive testing in dementia. Int J Methods Psychiatr Res 2009; 18: 118-127.
27. Wouters H, van Gool WA, Schmand B, Lindeboom R. Revising the ADAS-cog for a more accurate assessment of cognitive impairment. Alzheimer Disease Assoc Disorders 2008; 22: 236-244.
28. Tsuchida A, Doll BB, Fellows LK. Beyond reversal: a critical role for human orbitofrontal cortex in flexible learning from probabilistic feedback. J Neurosci 2010; 30: 16868-16875.
29. Heberlein AS, Padon AA, Gillihan SJ, Farah MJ, Fellows LK. Ventromedial frontal lobe plays a critical role in facial emotion recognition. J Cogn Neurosci 2008; 20: 721-733.
30. Tsuchida A, Fellows LK. Lesion evidence that two distinct regions within prefrontal cortex are critical for n-back performance in humans. J Cogn Neurosci 2009; 21: 2263-2275.
31. Aron AR, Fletcher PC, Bullmore ET, Sahakian BJ, Robbins TW. Stop-signal inhibition disrupted by damage to right inferior frontal gyrus in humans. Nat Neurosci 2003; 6: 115-116.
32. Modirrousta M, Fellows LK. Dorsal medial prefrontal cortex plays a necessary role in rapid error prediction in humans. J Neurosci 2008; 28: 14000-14005.
33. Robbins TW, James M, Owen AM et al. A study of performance on tests from the CANTAB battery sensitive to frontal lobe dysfunction in a large sample of normal volunteers: implications for theories of executive functioning and cognitive aging. Cambridge Neuropsychological Test Automated Battery. J Int Neuropsychol Soc 1998; 4: 474-490.
34. Owen AM, Roberts AC, Hodges JR, Summers BA, Polkey CE, Robbins TW. Contrasting mechanisms of impaired attentional set-shifting in patients with frontal lobe damage or Parkinson's disease. Brain 1993; 116 (Pt 5): 1159-1175.
35. Spreen O, Benton AL. Neurosensory Center Comprehensive Examination for Aphasia: Manual of instructions (NCCEA), rev. ed. Victoria: University of Victoria, 1977.
36. Wechsler D. Wechsler Adult Intelligence Scale-Administration and Scoring Manual, 3rd ed. San Antonio: The Psychological Corporation, 1997.
37. Matthews C, Klove K. Instruction manual for the Adult Neuropsychology Test Battery. Madison: University of Wisconsin Medical School, 1964.
38. Smith EV, Smith RM. Introduction to Rasch Measurement: Theories, Models and Applications. Maple Grove: Jam Press, 2004.
39. Wolfe EW, Smith EV Jr. Instrument development tools and activities for measure validation using Rasch models: part II-validation activities. J Appl Meas 2007; 8: 204-234.
40. Clifford DB. Viral escape in cerebrospinal fluid-an achilles heel of HIV therapy? J Infect Dis 2010; 202: 1768-1769.
41. Wouters H, de Koning I, Zwinderman AH et al. Adaptive cognitive testing in cerebrovascular disease and vascular dementia. Dement Geriatr Cogn Disord 2009; 28: 486-492.
42. Haley SM, Coster WJ, Andres PL, Kosinski M, Ni P. Score comparability of short forms and computerized adaptive testing: simulation study with the activity measure for post-acute care. Arch Phys Med Rehabil 2004; 85: 661-666.